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SUMMARY
A patient with a 13-year history of Hodgkin's disease, who
developed the terminal complication of amyloidosis mani-
festing in a nephrotic syndrome resul~ing in death, is re-
ported. The incidence of this rare complication is reviewed
from reports in the literature; to date only 53 unequivocal
cases of amyloidosis, in association with Hodgkin's
disease, have been described. The clinical picture is cis-
cussed, and the possible pathogenesis of amyloidosis is
considered. The importance of intensive combination
chemotherapy for preventing long-term complications, is
stressed.
S. Afr. Med. J., 47, 62 (1973).
Medical students are well acquainted with the condition
of amyloidosis, yet medical practitioners seldom see a
patient with amYloidosis. The purpose of this report is
to illustrate the clinical appearance of this condition, as
well as to draw attention to the fact that amyloidosis
may be a fatal complication in a patient with well-con-
trolled malignant disease, and lastly, to consider the
pathogenesis and suggest another important immunologi-
cal effect of neoplastic disease.
Rokitansky, in 1842, first described the disease entity
in which many organs exhibited a firm waxy substance,
due to the deposition of a homogeneous material. Virchow,
in 1854, noted that this substance stained blue-black
with iodine and sulphuric acid, almost like starch; he
therefore called the substance 'amyloid' and the disease
entity 'amyloidosis'. Actually, the substance has no re-
lationship to starch, but is a protein of variable composi-
tion, usually associated with a sulphate-bearing poly-
sacchride similar to, if not identical with, cho.ndroitin-
sulphuric acid. Wilks, in 1856, was the first to note that
this condition may follow chronic suppurative disease.
It has been known that there must be several
types of amyloidosis. At first secondary, or more correctly
perireticular amyloidosis, completely dominated the
picture. This form occurred only in patients who suffered
from chronic, mostly suppurati.ng disease. It was therefor~
regarded as secondary to such primary diseases as
tuberculosis, osteomyelitis and neoplastic disease.
Waldenstrom' was able to show that this condition was
reversible when the primary disease was successfully
treated. Primary amyloidosis is not preceded by a
discernible cause; increasing knowledge regarding 'primary
amyloidosis' or paramyloid that is also pericollagenous,
has led to the detection of many different types possibly
caused by different mechani<ms. From studies in many
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reported cases, it would appear that pnmary and secon-
dary amyloidosis have much in common. The primary
form with its pericollagenous amyloid depositions mainly
in mesechymal organs, affects especially muscular organs
such as heart, tongue, gastro-intestinal tract and muscles;
whereas the secondary form with perireticular amyloi-
dosis, is more commonly located in parenchymal organs
like liver, kidney, spleen and adrenals. However, mesen-
chymal tissue and parenchyma'tous organs are often
affected in both, and it is maintained by some pathologists
that primary and secondary amyloidosis have different
histologic pictures.' .
Amyloidosis as a complication of Hodgkin's disease
is a rare, though well-attested complication. As far back
as 1856, Wilks reported a case in which gross autopsy
material showed the existence of both diseases. However,
when 20 standard textbooks of medicine were consulted,
it was found that only 6 of these mentioned amyloidosis
as a complication of Hodgkin's disease.
A review of the literature reveals only 53 cases of
Hodgkin's disease in which the concurrent existence of
amyloidosis is either demonstrated by pathologic material
obtained at autopsy, or suggested by clinical studies.""
(Equivocal cases, or those with coexistent tuberculosis
are excluded.) It is difficult to obtain reliable figures
relating to the incidence of amyloidosis in Hodgkin's
disease; in the early literature there are no reliable
figures at all, because the diagnostic criteria for
differentiating Hodgkin's disease from tuberculosis were
not adequate, and also because many cases of Hodgkin's
disease, in those days, were complicated by tuberculosis.
Of the few recorded series, the following incidence is
reported: 2%: 4 %;., 8%;4 only one series showed a
surprisingly high incidence, namely, of 20 amyloidosis
cases, 4 were diagnosed as secondary to Hodgkin's
disease." The words 'rare' and 'occasional' in textbooks
and monographs are therefore justified.
The clinical picture of amyloidosis depends upon the
organs involved; renal disease is a major component in
most patients. The association of Hodgkin's disease and
~:le nephrotic syndrome, due to amyloidosis, is rare.'
When this association does occur, it is usual for the
nephrotic syndrome to appear after the picture of Hodg-
kin's disease is well established. It is generally accept~d
that the nephrotic syndrome results from a glomerular
abnormality, which has as its cardinal sign massive
proteinuria; other features such as hypo-albuminaemia,
lipiduria, hypercholesterolaemia and oedema, are more
variable. "
There has been very little exact knowledge of the
source or mode of formation of amyloid. Early studies
suggested that amyloid deposits were caused by precipita-
tion of circulating gamma globulin in the tissues. and
13 JallUarie 1973 S.-A. MEDIESE TVDSKRIF 63
later work raised the possibility that specific antibodies
(0 the inducing agent may play a causative role."'"
These concepts lost favour when it was noted that patients
with severe hypogammaglobulinaemia sometimes develop
amyloidosis, and when it was shown that amyloid fibrils
do not react with antisera to human IgO and its subunits.
Teilum 14 propounded a so-called 'two-phase cellular theory
of local secretion', where the common fundamental
lesion in various forms of amyloidosis is a failure of
normal differentiation and maturation of plasmocytoid
and other pyroninophilic reticular cells, under the stress
of protracted stimulation. He suggested that the effects
of cortisone, ACTH and nitrogen mustard, through
suppression of the reticulo-endothelial cells, wou'd be
acceleration of the amyloid process. Lately, attention
has been directed to a closer temporal relation between
amyloid formation and impaired cellular immunity."
Conditions which favour the depletion of small lym-
phocytes can all accelerate, or enhance, th.e development
of amyloid. Cathcart and co-workers'· suggest that ex-
perimental amyloidosis (and possibly other amyloidotic
states), is the end-product of a specific clone of inac-
tivated lymphocytes. As long as the specific antigenic
challenge is sustained, amyloid production would be
enhanced, but once the antigenic stimulus is removed,
amyloid production would cease. Non-specific factors
such as blood supply and renal clearance, might also
influence the rate and site of deposition of newly-formed
:1myloid.
CASE REPORT
Thirteen years ago, a 30-year-old White woman pre en ted
with severe pruritus, weight loss and a swelling in the
neck. Biopsy of the left supraclavicular lymph glands
confirmed the diagnosis of 'Hodgkin's disease. Treatment
with radiotherapy and cyclophosphamide gave a partial
remission. Four years later, she developed a large mass
in the right fossa iliaca, as well as enlarged inguinal
glands. Radiation over the affected area resulted in
improvement, but within a year she was very ill with
anaemia, weakness, weight loss and a very large abdominal
mass. Her disease was then fully controlled with vin-
blastine injections. She remained in complete remission
for 4 years, but then had a relapse, with weakness,
weight loss, fever, night sweat and the mass in the right
fossa iliaca again enlarged. At this stage, her sedimen-
tation rate was 54 mm in the 1st hour (Westergren),
serum albumin was 3,6 g/IOO ml, globulin 4,5 g/IOO ml
and ga.!nma globUlin 1,2 g/lOO ml, her serum copper
was 306 p.g, and Reed-Sternberg cells were found in
the bone marrow. Treatment with procarbazine. vin-
cristine, chlorambucil and prednisone procured a complete
remission, lasting one year. Her serum calcium content
was normal except for a period of 5 months when
increased values were recorded. 0 reason for these
increased valueS' could be found, and strontium uptake
and roentgenologic examination of the keleton showed
no bone lesions.
The patient relapsed again. with enlargement of (he
same glands in the right fossa iliaca, a well as hepa-
tomegaly: he complained of evere pruritus and lost
an appreciable amount of weight. She was found to
be anaemic, with a haemoglobin of 8,5 g/ 100 ml, her
sedimentation rate was 53 mm/ h, the alkaline ph.os-
phatase was increased to 26 IU, the serum copper was
366 g, her serum albumin was 1,7 g/ 100 ml, the globulin
2,4 g/l00 ml and the gamma globulin 0,4 g/lOO m!.
Combination chemotherapy with bis-cblorethyl-nitroso-
urea (BCND), vincristine and a prednisone procureD a
complete remission, and after a 6-month induction treat-
ment period, she was given maintenance treatment with
chlorambucil per os and periodic reinduction injections
of vincristine. The hepatomegaly had disappeared, the
glands in the fossa iliaca had virtually disappeared and
symptomatically the patient was quite well. Her haemo-
globin had now increased to 13,6 g/IOO ml; the sedi-
mentation and serum copper, however, remained high
throughout this asymptomatic period. Her serum albumin
varied between 2,8 and 4,0 g/IOO ml, the globulin from
3,0 to 5,2 g/100 ml and the gamma globulin from
0,2 to 2,4 g!IOO m!. Five months after the start of this
intensive combination therapy an abnormal serum
electrophoretic macroglobulin was recorded; this was
noted only once and never recurred.
This remission lasted for 2 years; she then relap ed
with the following symptoms: febrile attacks up to
40°C, cold shivers, an extensive maculopapular rash
(histologically this was an allergic vasculitis), evere
pruritus and malaise to the point of exhaustion. A
gallium scan showed increased retention, therefore
Hodgkin's involvement of para-aortic glands wa us-
pected; however, there was no other indication of
reactivation of the Hodgkin's disea e. The patient's
urine showed a 4 + proteinuria, but no organisms.
Serological te ts for schisto oma, salmonella, rickettsia
and brucellosis were all negative. The patient's complaint.
of tiredness and febrile attacks la ted for one month.
then her condition rapidly deteriorated and he developed
a serious diarrhoea. She was then admitted to ho pita!
in an exhausted state. Physical examination showed
puffy oedema of the face, as well as oedema of both
legs; there were DO respiratory or cardiovascular abnor-
malities, except for a rather low range of systolic and
diastolic blood pressure (systolic 80-70 and diastolic
50-30), the abdomen was distended, but no ascites or
organomegaly were detected. Her alkaline phosphatase
at this stage was 57,5 IU, SOOT was 69 Transac IU,
blood urea was 50 mg/IOO ml, blood creatinine was
1,0 mg/lOO ml, blood uric acid was 8,8 mg/IOO ml, the
total serum protein was now only 3,2 g/100 ml, the
albumin was 0,7 g/lOO ml, globulin was 2,5 g/IOO ml
and gamma globulin was 0,3 g/lOO m!. Symptomatic
treatment gave little relief, and she died 10 days after
admission.
Tecropsy
There was 5erous fluid in both pleural cavlltes (150 ml
left and 300 ml right), both lung exhibited some conge -
tion and oedema. The heart weighed 250 g and except
for moderate atherosclero is, no other gross abnormalities
were noted. There were enlarged lymph glands in the
64 S.A. MEDICAL JOURNAL 13 January 1973
area of the pulmonary aorta. Several superficial ulcers
were seen in the oesophagus and stomach. The liver
weighed 2 000 g, looked pale and as though there might
have been tumour infiltration. The kidneys weighed
150 g (right) and 110 g (left) with no visible abnormalities.
There was haemorrhagic cystitis, with a deep ulcer in
the superior surface of the bladder. Both adrenals weighed
7 g and some enlarged gland masses surrounded them.
The spleen weighed 400 g and infiltration masses were
visible; enlarged lymph glands were found in the media-
stinum and para-aortic area. No other noteworthy changes
were present in the body.
Histology
The enlarged lymph glands showed typical lesions of
nodular sclerosing Hodgkin's disease. Extensive amyloid
deposits were present in the kidneys, spleen, liver, adrenals
and stomach. Sections of all other organs showed no
Hodgkin's disease or amyloidosis; a moderate amount
of interstitial fibrosis was present in the myocardium,
and there was some pulmonary congestion, with
centrilobular emphysema.
Comment
This is a typical case of Hodgkin's disease, with a
long history of disease control with radiotherapy and
chemotherapy; it should be noted that this patient was
never treated with nitrogen mustard. She enjoyed years
of clinical remission, alihough a persistently high sedi-
mentation rate and serum copper level, as well as a
positive gallium scan, suggested disease activity even
during the remissions. A month before exitus, she
relapsed with tiredness and spiking fever; at this stage
an extensive search for any form of infection was negative.
Her serum albumin started to drop, while the serum
globulin was higher than normal. Two weeks before
death, she was admitted in an exhausted state with 4 +
albuminuria and oedema. The total serum protein had
dropped at this stage to 3,2 g/lOO ml with a hypo-albu-
minaemia of 0,7 g/loo ml. The blood urea remained
within normal limits till a preterminal raise of 50 mg/100
m!. The patient was too ill for a renal biopsy or other
special investigations to determine the cause of the
nephrotic syndrome. Amyloidosis of kidneys, adrenals,
liver, spleen and stomach was found at autopsy.
DISCUSSION
Amyloidosis as a complication of Hodgkin's disease is
considered to be rare. From a survey of the literature
it appears that only a small number (53) of such cases
has been reported throughout the years. The incidence
of this complication could hardly be more than 1%, it is
most likely still less. Renal disease usually dominates
the picture in perireticular amyloidosis, but the associa-
tion of Hodgkin's disease and the nephrotic syndrome,
due to amyloidosis, is unusual. In the case presented here,
the diagnosis of amyloidosis was not made antemortem.
It was suspected that her nephrosis could be based on
pressure by retroperitoneal glands, or even by the direct
infiltration of the kidneys, which is very rare. The treat-
ment of secondary perireticular amyloidosis is mainly
that of the primary causative disease.
From the case report it will be evident that the thera-
peutic armamentarium had been exhausted in this
individual; attention is drawn to the fact that this patient
was not initially treated with current combination
chemotherapy. Not only is the incidence of remissions
in extensive and advanced Hodgkin's disease, as well as
the quality of these remissions, so infinitely better with
modern intensive combination chemotherapy, but it is
also aimed at avoiding long-term complications, such
as amyloidosis. Although early reports implicated injec-
tions of nitrogen mustard as an enhancing factor in
amyloidosis/"I< modern therapy of Hodgkin's disease
has not been implicated as accelerating amyloid formation.
In the investigation of the relationship between amyloid
formation and impaired cellular immunity, a great
number of factors which can enhance the development
of amyloid have been implicated: thymectomy,"
splenectomy, 18 iOIDZmg radiation, 10 antimetabolites,'·
cortisone," parabiosis" and other conditions which favour
the depletion of small lymphocytes." It appears that
amyloidosis is an expression of immunological tolerance.
The fact that immunology is concerned in the development
of tumours, the rate of growth and metastasis, and the
clinical state of patients with neoplastic disease, is generally
accepted. The occurrence of amyloidosis as a complication
of Hodgkin's disease, points to another immunological
facet in malignant disease.
We wish to acknowledge the help of Professor J. Simson
of the Department of Pathology, in establishing the post-
mortem diagnosis.
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